Literature DB >> 25552167

Stress indicators during general anesthesia with opioid analgesics in children.

Biljana Draskovic1, Danica Stanic, Anna Uram-Benka, Izabella Fabri.   

Abstract

BACKGROUND/AIM: To determine which of the applied opioid analgesics brings the most powerful blockade of the stress response with the fewest side effects in children.
MATERIALS AND METHODS: This was a prospective, observational clinical study. The study included 150 boys, aged 2-5 years, ASA I, who underwent herniectomy or orchidopexy in day case surgery. The introduction and maintenance of anesthesia was intravenous (propofol, rocuronium, and opioids); airway was maintained by laryngeal mask and ventilation by mixture of oxygen/air. Subjects were divided into 3 groups depending on the applied opioid analgesics (fentanyl, alfentanil, remifentanil).
RESULTS: The fentanyl group had the highest blood glucose values (AS = 5.14; SD = 0.47) and the highest increase in cortisone level at the moment of incision and at awakening (AS = 536.09; SD = 198.56). The lowest increase in cortisone was recorded in the remifentanil group. A significant decrease in leptin was registered at awakening in the fentanyl group and at the moment of incision in the remifentanil group (P= 0.939).
CONCLUSION: Remifentanil is the opioid analgesic with the highest suppressing effect on the stress response to surgical intervention in children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25552167     DOI: 10.3906/sag-1305-36

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  2 in total

1.  Effect of ketamine combined with butorphanol on emergence agitation of postoperative patients with gastric cancer.

Authors:  Liang Lin; Shuncui Liu; Zhenyi Chen; Shaoli Lin
Journal:  Ther Clin Risk Manag       Date:  2016-05-04       Impact factor: 2.423

2.  Total Intravenous Anesthesia in GLUT1 Deficiency Syndrome Patient: A Case Report.

Authors:  Jan Kloka; Stefanie Kranepuhl; Kai Zacharowski; Florian Jürgen Raimann
Journal:  Am J Case Rep       Date:  2019-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.